Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Breuer J, Joppi R, Poggiani C, Dabrowska M, Zawodnik A. Obinutuzumab (Gazyva®) for previously untreated patients with chronic lymphocytic leukaemia (CLL) Vienna: Ludwig Boltzmann Institut fuer Health Technology Assessment (LBIHTA). DSD: Horizon Scanning in Oncology No. 45. 2014 Indexing Status Subject indexing assigned by CRD MeSH Antibodies, Monoclonal, Humanized; Leukemia, Lymphocytic, Chronic, B-Cells Language Published English Country of organisation Austria English summary An English language summary is available. Address for correspondence Ludwig Boltzmann Institute fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7 rechte Stiege Mezzanin (Top 20), 1090 Vienna, Austria. Tel: +43 1 236 8119 - 0 Fax: +43 1 236 8119 - 99 Email: anna.nachtnebel@hta.lbg.ac.at AccessionNumber 32014000985 Date abstract record published 13/08/2014 |